[go: up one dir, main page]

US3908003A - Enrobed solid hydrophobic tableting lubricants and compositions - Google Patents

Enrobed solid hydrophobic tableting lubricants and compositions Download PDF

Info

Publication number
US3908003A
US3908003A US449171A US44917174A US3908003A US 3908003 A US3908003 A US 3908003A US 449171 A US449171 A US 449171A US 44917174 A US44917174 A US 44917174A US 3908003 A US3908003 A US 3908003A
Authority
US
United States
Prior art keywords
lubricant
enrobed
tableting
hydrophilic
solid hydrophobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US449171A
Inventor
Marvin Hersh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Priority to US449171A priority Critical patent/US3908003A/en
Application granted granted Critical
Publication of US3908003A publication Critical patent/US3908003A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds

Definitions

  • the rate of disintegration of the compact should ideally not be impeded by the processing or additives required to convert the active constituents into a convenient, stable and easily ingestible oral dosage form.
  • the conventional procedure for making compacts requires the addition of a lubricant to the mixture before compression. Compression is accomplished by subjection of the tablet mix to high pressures by moveable punches operating in a die wherein the tablet mix is confined.
  • the lubricant generally fine particles of solid material typified by such hydrophobic, antiadherent materials as metallic stearates, fatty acids, talc and natural and synthetic waxes, is necessary to allow the ready ejection of the formed compact and to prevent the binding of the punches in the die. Lubrication is required only at the tablet-die interface to prevent sticking of the newly formed compact to the die walls.
  • existing practical approaches to tablet lubrication require homogeneous distribution of lubricant within the entire tablet granulation (see for example: Remingtons Practice of Pharmacy, 12th edition, 1961, Mack Publishing Co., Page 448).
  • US. Pat. No. 3,l58,l l 1 discloses a timed spray to lubricate thepunch and die surfaces, the lubricant being dispersed in and distributed by an aerosol propellant.
  • U.S. Pat. No. 3,042,531 teaches a dual cycle compression system in which a tablet containing only lubricant and carrier is first compressed within a die and then ejected leaving a residue of lubricant on the punch and die surfaces providing external lubrication for a second active granulation which is subsequently introduced and compressed.
  • the invention sought to be patented in a principal composition aspect resides in the concept of finely divided particles of solid hydrophobic tableting lubricant, a substantial proportion of the particles of said lubricant being enrobed in a hydrophilic friable sheath.
  • the tangible embodiments of the principal composition aspect of the invention possess the applied use characteristic of supplying necessary lubrication at points of high shear when present in a tableting formulation subject to compression according to standard methods for compact formation.
  • the hydrophilic envelope will selectively rupture at points of high shear such as the compact-die wall interface thus releasing the entrapped lubricant where it is needed.
  • the enrobed solid hydrophobic lubricant particles in the interior of the compact as well as on the top and bottom surfaces will remain intact and present none of the antiadherent, hydrophobic characteristic properties of conventional, unprocessed lubricants.
  • the invention sought to be patented in a second composition aspect resides in the concept of a solid compact comprising finely divided particles of solid hydrophobic tableting lubricant, a substantial proportion of the particles of said lubricant being enrobed in a hydrophilic friable sheath.
  • the tangible embodiments of the second composition aspect of the invention possess the applied use characteristic of being compacts with improved disintegration characteristics capable of formation by standard tableting procedures known in the art.
  • the invention sought to be patented in a principal process aspect resides in the concept of a process for the production of a compact which comprises incorporating in a mixture to be compacted finely divided particles of solid hydrophobic tableting lubricant, a substantial proportion of said particles being enrobed in a hydrophilic friable sheath, and applying thereto a sufficient compressive force.
  • the conventional tableting excipients such as binders, fillers, glidants, disintegrants, flavors and colorants may be mixed with a specially prepared enrobed solid hydrophobic lubricant before compaction.
  • This solid hydrophobic lubricant has previously been treated to enclose it within a non-hydrophobic, friable sheath or envelope.
  • This relatively inelastic envelope is designed to selectively rupture only at areas of high shear during compaction, such as the tablet-die wall interface, and remain intact in the interior of the tablet.
  • the entrapped solid hydrophobic lubricant released from the ruptured enrobed lubricant particle functions only where actually required.
  • the enrobed lubricant particles in the interior of the tablet remain intact and present none of the anti-adherent, hydrophobic properties of conventional, unprocessed lubricants. Thus, dispersal of fluids within the tablet interior is facilitated and the availability of the contained active ingredient is improved.
  • the enrobed particles on the top and bottom of the tablet also remain substantially intact, thus providing free entry of the dissolution fluid. These surface particles, while subjected to high compressive forces during compaction are not ruptured, because no true shearing or sliding forces are exerted on these areas. Shear, in this context, is considered as stress resulting from applied forces that cause two contiguous surfaces to slide relatively to each other in a direction parallel to their plane of contact.
  • the designed mechanical function of this method may be visually indicated by dye tracers incorporated in the envelope surrounding the lubricant particle.
  • the sides or lands of the other wise uncolored compressed tablets show dye streaks parallel to the path of ejection, while examination of bisected tablets show intact unchanged enrobed particles in the tablet interior.
  • the enrobed solid hydrophobic lubricants of the present invention can be prepared by a variety of processes, such as:
  • micropellets Formation of hydrophilic micropellets from geletin, gum arabic, methyl cellulose, polyvinyl, alcohol, or the like, said micropellets containing solid hydrophobic tableting lubricant particles.
  • the technique for preparation of micropellets containing particulate material is described in N. Tanaka, S. Takino, and I. Utsumi, J. Pharm. Sci., 52, 664 (1963).
  • any of the various solid hydrophobic tableting lubricants may be used in this invention.
  • these are magnesium stearate, calcium stearate, talcum, fatty acids, stearic acid, and powdered vegetable stearine.
  • Other suitable tableting lubricants will readily suggest themselves and the utilization in the practice of the invention of any of a vast number of substances suitable as lubricants is well within the skill of the art.
  • hydrophilic substances may be utilized as the coating materials in the present invention.
  • hydrophilic mate ials contemplated by the present invention are such substances as gelatin, gum arabic, methyl cellulose, carboxymethylcellulose, polyvinyl alcohol, mannitol, polyethylene glycol 4,000, 6,000, and 20,000, and other hydrophilic materials which will be obvious to those skilled in the art.
  • hydrophilic mate ials contemplated by the present invention are such substances as gelatin, gum arabic, methyl cellulose, carboxymethylcellulose, polyvinyl alcohol, mannitol, polyethylene glycol 4,000, 6,000, and 20,000, and other hydrophilic materials which will be obvious to those skilled in the art.
  • the thickness of the enrobing material which surrounds the lubricant particles is not critical. The shearing forces generated during compaction are extremely large and are more than sufficient to rupture the various sheath thicknesses which may
  • the optimal thickness of the friable sheath will vary with the particular substances utilized, or the particular coating procedures used; however, the optimal thickness, or optimal range of thicknesses for a particular combination of lubricant and sheathing material may be readily determined by those skilled in the art.
  • the compacts prepared utilizing the present invention may be multilayer compacts and have various different shapes and sizes. Further, that these compacts once formed may be coded and/or coated by a variety of procedures well-known to those skilled in the art. Still further, they may be subjected to a polishing procedure or other routine processes which have been carried out on compacts prior to this invention.
  • Additional advantages of this invention include the improvement of physical properties of compressed tablets even where availability of the actives is not a factor. As an example, harder, less friable and more rapidly disintegrating tablets may be obtained with the enrobed solid hydrophobic lubricant particles of the invention than with an equivalent quantity of unprocesses lubricant.
  • Polyethylene glycol 4000 g. is heated until molten (6065 C. and dry, finely powdered magnesium stearate U.S.P. (10 g.) is added with mechanical stirring. This stirred dispersion is cooled to room temperature (ca. 25 C.) and chilled further with solid carbon dioxide. The solid is milled through a US. No. 30 screen producing the enrobed tableting lubricant which is suitable for use in conventional tableting procedures.
  • EXAMPLE ll 33% Magnesium Stearate Enrobed in Gelatin To a suspension of gelatin (40 g.) in water (200 g.) is added finely powdered magnesium stearate USP. (20 g.) with rapid stirring. This mixture is warmed on a steam bath to form a solution and poured into mineral oil (600 g.) heated to ca. 5560 C. The total mixture is stirred at 1822 r.p.m. for 5 minutes and quickly cooled to ca. 5 C. producing gelatin micropellets containing magnesium stearate. The micropellets are washed with isopropanol and dried. The dried micropellets produced in this manner are suitable for use as a lubricant in conventional tableting procedures.
  • EXAMPLE lV Talc Enrobed in Polyethylene Glycol 6000 by Spray Chilling Dry powdered talc (25 g.) is suspended in molten polyethylene glycol 6,000 (250 g.) and stirred until homogeneous. This suspension is sprayed into a chilled chamber with cold air causing the polyethylene glycol 6,000 to solidify about the tale particles. In this manner talc particles coated with polyethylene glycol 6,000 may be obtained which are suitable for use as a tableting lubricant in a conventional tableting procedure.
  • Tablet disintegration time was reduced from 23' minutes for a control tablet containing a conventional lubricant to 17 minutes for a tablet containing an equivalent amount of the enrobed lubricant.
  • T and T is time in minutes necessary for dissolution of 50% and 80%
  • said sheathing material being selected from the group consisting of mannitol, polyethylene glycol 4,000, 6,000, and 20,000, gelatin, methyl cellulose, carboxymethylcellulose, gum arabic, and polyvinyl alcohol; said enrobed tableting lubricant imparting a reduction in dissolution time to a compacted pharmaceutical dosage form when incorporated in said compacted pharmaceutical dosage form, as compared to said lubricant when not enrobed.
  • composition of claim 1 wherein the solid hydrophobic tableting lubricant is magnesium stearate and the hydrophilic friable sheathing material is poly ethylene glycol 4000.
  • composition of claim 1 wherein the solid hydrophobic tableting lubricant is magnesium stearate and the hydrophilic friable sheathing material is gelatin.
  • composition of claim 1 wherein the solid hydrophobic tableting lubricant is calcium stearate and the hydrophilic friable sheathing material is gelatin.
  • a compressed pharmaceutical medicament tablet containing as tableting lubricant a tableting lubricant composition consisting essentially of micropellets of finely divided particles of solid hydrophobic tableting lubricant selected from the group consisting of magnesium stearate, calcium stearate, stearic acid, talcum, and powdered vegetable stearine, a substantial proportion of the particles of said lubricant being enrobed in a hydrophilic friable sheath, said sheathing material being selected from the group consisting of mannitol, polyethylene glycol 4,000, 6,000, and 20,000, gelatin, methyl cellulose, carboxymethylcellulose, gum arabic, and polyvinyl alcohol; said tablet having imparted, by said enrobed lubricant, reduced disintegration time compared to said lubricant if not enrobed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Conventional solid hydrophobic tableting lubricants enrobed in a hydrophilic friable sheath are disclosed. The utilization of these enrobed lubricants with conventional tableting equipment makes possible the preparation of compacted tablets with improved dissolution times.

Description

United States Patent 1191 1111 3,908,003
Hersh Sept. 23, 1975 [54] ENROBED SOLID HYDROPHOBIC 3,382,150 5/1968 Grass et al.... 424/32 TABLETING LUBRICANTS AND 3,518,343 6/1970 Wolsh et al... 424/44 3,518,344 6/1970 Wolsh et a1... 424/44 COMPOSITIONS 3,518,345 6/1970 Dinos et al.... 424/44 [75] Inventor: Marvin Hersh, Strafford, Pa, 3,619,462 11/1971 Dinos et al 264/300 [73] Assignee: American Home Products OTHER PUBLICATIONS Corporation, New York, N.Y. Little et al., Tablet Making, 2nd Ed. (1963), pp. 22 F1 d. M 7, 1974 1 l 8 M 64-65 Northern Pub. Co. Liverpool, England. [21] Appl, No.: 449,171
Related Application Data Primary Examirier- Shep K. Rose [63] Continuation-impart of Ser. No. 159,569, July 2, Attorney, Agent, or FirmRobert Wiser 1971, abandoned.
[52] U.S. Cl. 424/32; 252/10; 264/300; [57] S R C 424/357; 424/365 Conventional solid hydrophobic tableting lubricants [51] Int. Cl. A61K 27/00 enrobed in a hydrophilic friable sheath are disclosed. [58] Field of Search 424/32-38, The utilization of these enrobed lubricants with con- 424/357, 365; 264/300; 252/10 ventional tableting equipment makes possible the preparation of compacted tablets with improved disso- [56] References Cited lution times.
UNITED STATES PATENTS 6 Cl N D 3,210,208 10/1965 Grass et al. 106/148 o rawmgs ENROBED SOLID HYDROPI-IOBIC TABLETING LUBRICANTS AND COMPOSITIONS CROSS-REFERENCE TO RELATED APPLICATION This application is a continuation-in-part of US. Patent application Ser. No. 159,569, filed July 2, l97l, now abandoned.
BACKGROUND OF THE INVENTION em. The rate of disintegration of the compact should ideally not be impeded by the processing or additives required to convert the active constituents into a convenient, stable and easily ingestible oral dosage form. However, in practice, it is usually necessary to include in the tableting composition agents which impart physical characteristics essential for manufacture with existing compaction equipment, but having adverse effects on tablet disintegration and thus on the availability of the active components.
The conventional procedure for making compacts requires the addition of a lubricant to the mixture before compression. Compression is accomplished by subjection of the tablet mix to high pressures by moveable punches operating in a die wherein the tablet mix is confined. The lubricant, generally fine particles of solid material typified by such hydrophobic, antiadherent materials as metallic stearates, fatty acids, talc and natural and synthetic waxes, is necessary to allow the ready ejection of the formed compact and to prevent the binding of the punches in the die. Lubrication is required only at the tablet-die interface to prevent sticking of the newly formed compact to the die walls. However, existing practical approaches to tablet lubrication require homogeneous distribution of lubricant within the entire tablet granulation (see for example: Remingtons Practice of Pharmacy, 12th edition, 1961, Mack Publishing Co., Page 448).
The inclusion of an anti-adherent lubricant between granules intended for compression and cohesion in a compact is a paradoxical reality of tableting. Cohesion of adjacent granules is desired to form a structurally adequate compact; however, wh en anti-adherent lubricant particles are interspersed between these granules, cohesion is reduced and a weak compact results. Similarly, the presence of hydrophobic lubricant particles in a compressed matrix surrounding active material which is intended for rapid dissolution and absorption is a negative design. The movement of fluid through intergranular passages is desired in order to initiate the disintegration of the compressed tablet thus allowing the active components to be absorbed by the host. The presence throughout the tablet of hydrophobic lubricant particles, however, impedes this distribution of solvent into the tablet interior, thus increasing disintegration time for the compact.
The desirability of providing lubrication only on the tablet sides or lands is indicated by prior efforts to obtain external lubrication of the die surfaces. Various methods and techniques of spraying or insufflating lubricants in solution or as small particle size solids have been used. These methods require elaborate mechanical components, do not precisely or uniformly deposit lubricant films where needed and are difficult to regulate and adjust for changes in tableting rates.
US. Pat. No. 3,l58,l l 1 discloses a timed spray to lubricate thepunch and die surfaces, the lubricant being dispersed in and distributed by an aerosol propellant.
U.S. Pat. No. 3,042,531 teaches a dual cycle compression system in which a tablet containing only lubricant and carrier is first compressed within a die and then ejected leaving a residue of lubricant on the punch and die surfaces providing external lubrication for a second active granulation which is subsequently introduced and compressed.
SUMMARY OF THE INVENTION The invention sought to be patented in a principal composition aspect resides in the concept of finely divided particles of solid hydrophobic tableting lubricant, a substantial proportion of the particles of said lubricant being enrobed in a hydrophilic friable sheath.
The tangible embodiments of the principal composition aspect of the invention possess the applied use characteristic of supplying necessary lubrication at points of high shear when present in a tableting formulation subject to compression according to standard methods for compact formation. The hydrophilic envelope will selectively rupture at points of high shear such as the compact-die wall interface thus releasing the entrapped lubricant where it is needed. The enrobed solid hydrophobic lubricant particles in the interior of the compact as well as on the top and bottom surfaces will remain intact and present none of the antiadherent, hydrophobic characteristic properties of conventional, unprocessed lubricants.
The invention sought to be patented in a second composition aspect resides in the concept of a solid compact comprising finely divided particles of solid hydrophobic tableting lubricant, a substantial proportion of the particles of said lubricant being enrobed in a hydrophilic friable sheath.
The tangible embodiments of the second composition aspect of the invention possess the applied use characteristic of being compacts with improved disintegration characteristics capable of formation by standard tableting procedures known in the art.
The invention sought to be patented in a principal process aspect resides in the concept of a process for the production of a compact which comprises incorporating in a mixture to be compacted finely divided particles of solid hydrophobic tableting lubricant, a substantial proportion of said particles being enrobed in a hydrophilic friable sheath, and applying thereto a sufficient compressive force.
DESCRIPTION OF THE PREFERRED EMBODIMENTS In accordance with the present invention a method is now provided whereby conventional tableting equipment and standard tableting procedures are utilized to prepare compacted tablets having improved disintegration characteristics.
The conventional tableting excipients such as binders, fillers, glidants, disintegrants, flavors and colorants may be mixed with a specially prepared enrobed solid hydrophobic lubricant before compaction. This solid hydrophobic lubricant has previously been treated to enclose it within a non-hydrophobic, friable sheath or envelope. This relatively inelastic envelope is designed to selectively rupture only at areas of high shear during compaction, such as the tablet-die wall interface, and remain intact in the interior of the tablet. Thus, the entrapped solid hydrophobic lubricant released from the ruptured enrobed lubricant particle functions only where actually required. The enrobed lubricant particles in the interior of the tablet remain intact and present none of the anti-adherent, hydrophobic properties of conventional, unprocessed lubricants. Thus, dispersal of fluids within the tablet interior is facilitated and the availability of the contained active ingredient is improved. The enrobed particles on the top and bottom of the tablet also remain substantially intact, thus providing free entry of the dissolution fluid. These surface particles, while subjected to high compressive forces during compaction are not ruptured, because no true shearing or sliding forces are exerted on these areas. Shear, in this context, is considered as stress resulting from applied forces that cause two contiguous surfaces to slide relatively to each other in a direction parallel to their plane of contact. The designed mechanical function of this method may be visually indicated by dye tracers incorporated in the envelope surrounding the lubricant particle. The sides or lands of the other wise uncolored compressed tablets show dye streaks parallel to the path of ejection, while examination of bisected tablets show intact unchanged enrobed particles in the tablet interior.
The enrobed solid hydrophobic lubricants of the present invention can be prepared by a variety of processes, such as:
Dispersion of solid hydrophobic tableting lubricant particles in molten mannitol, polyethylene glycol 4,000, 6,000 and 20,000, or other thermostable hydrophilic materials whereby milling or other methods of particle size reduction, after solidification, results in substantial entrapment of lubricant particles in a solid non-hydrophobic matrix;
Coating of the solid hydrophobic tableting lubricant particles with a hydrophilic material by spray drying or spray chilling technique;
Formation of hydrophilic micropellets from geletin, gum arabic, methyl cellulose, polyvinyl, alcohol, or the like, said micropellets containing solid hydrophobic tableting lubricant particles. The technique for preparation of micropellets containing particulate material is described in N. Tanaka, S. Takino, and I. Utsumi, J. Pharm. Sci., 52, 664 (1963).
Any of the various solid hydrophobic tableting lubricants may be used in this invention. Among these are magnesium stearate, calcium stearate, talcum, fatty acids, stearic acid, and powdered vegetable stearine. Other suitable tableting lubricants will readily suggest themselves and the utilization in the practice of the invention of any of a vast number of substances suitable as lubricants is well within the skill of the art.
Many hydrophilic substances may be utilized as the coating materials in the present invention. Among the hydrophilic mate ials contemplated by the present invention are such substances as gelatin, gum arabic, methyl cellulose, carboxymethylcellulose, polyvinyl alcohol, mannitol, polyethylene glycol 4,000, 6,000, and 20,000, and other hydrophilic materials which will be obvious to those skilled in the art. There is no criticality in the use of any particular lubricant or hydrophilic Substance. The thickness of the enrobing material which surrounds the lubricant particles is not critical. The shearing forces generated during compaction are extremely large and are more than sufficient to rupture the various sheath thicknesses which may be applied by the methods described in this invention and other methods known in the art. The optimal thickness of the friable sheath will vary with the particular substances utilized, or the particular coating procedures used; however, the optimal thickness, or optimal range of thicknesses for a particular combination of lubricant and sheathing material may be readily determined by those skilled in the art.
It will be apparent to those skilled in the art that the compacts prepared utilizing the present invention may be multilayer compacts and have various different shapes and sizes. Further, that these compacts once formed may be coded and/or coated by a variety of procedures well-known to those skilled in the art. Still further, they may be subjected to a polishing procedure or other routine processes which have been carried out on compacts prior to this invention.
While it is the main object of this invention to provide an improved method of preparation of pharmaceutical compacts which possess an improved dissolution rate, it will be obvious to those skilled in the art that this improved method may be applied to compacts other than those which contain a medicament. Thus, compacted coloring and flavoring materials, spices, detergents, and even placebo tablets may be prepared utilizing the improved method of this invention.
Additional advantages of this invention include the improvement of physical properties of compressed tablets even where availability of the actives is not a factor. As an example, harder, less friable and more rapidly disintegrating tablets may be obtained with the enrobed solid hydrophobic lubricant particles of the invention than with an equivalent quantity of unprocesses lubricant.
The following non-limiting examples illustrate the best mode contemplated by the inventor of carrying out the processes of the invention.
EXAMPLE I 10% Magnesium Stearate Enrobed in Polyethylene Glycol 4000, U. S. P.
Polyethylene glycol 4000 g.) is heated until molten (6065 C. and dry, finely powdered magnesium stearate U.S.P. (10 g.) is added with mechanical stirring. This stirred dispersion is cooled to room temperature (ca. 25 C.) and chilled further with solid carbon dioxide. The solid is milled through a US. No. 30 screen producing the enrobed tableting lubricant which is suitable for use in conventional tableting procedures.
EXAMPLE ll 33% Magnesium Stearate Enrobed in Gelatin To a suspension of gelatin (40 g.) in water (200 g.) is added finely powdered magnesium stearate USP. (20 g.) with rapid stirring. This mixture is warmed on a steam bath to form a solution and poured into mineral oil (600 g.) heated to ca. 5560 C. The total mixture is stirred at 1822 r.p.m. for 5 minutes and quickly cooled to ca. 5 C. producing gelatin micropellets containing magnesium stearate. The micropellets are washed with isopropanol and dried. The dried micropellets produced in this manner are suitable for use as a lubricant in conventional tableting procedures.
EXAMPLE lll Calcium Stearate Enrobed in Gelatin by Spray Drying Dry powdered calcium stearate g.) is suspended in a 1% gelatin solution (500 cc.) and the suspension is spray dried to remove the water. In this mar ner gelatin coated calcium stearate particles are obtained which are suitable for use as a tableting lubricant in a conventional tableting procedure.
EXAMPLE lV Talc Enrobed in Polyethylene Glycol 6000 by Spray Chilling Dry powdered talc (25 g.) is suspended in molten polyethylene glycol 6,000 (250 g.) and stirred until homogeneous. This suspension is sprayed into a chilled chamber with cold air causing the polyethylene glycol 6,000 to solidify about the tale particles. In this manner talc particles coated with polyethylene glycol 6,000 may be obtained which are suitable for use as a tableting lubricant in a conventional tableting procedure.
EXAMPLE V Tablets having the following composition are prepared with conventional tableting equipment:
Tablet disintegration time was reduced from 23' minutes for a control tablet containing a conventional lubricant to 17 minutes for a tablet containing an equivalent amount of the enrobed lubricant.
EXAMPLE Vl Antibiotic tablets having the following composition and showing the superior dissolution characteristics tabulated are prepared as follows:
Ingredient mg. per tablet Potassium Penicillin G, U.S.P. 166.0 Gelatin Enrobed Lubricant [8.0 (33% Magnesium stearate. U.S.P.) Calcium Carbonate, U.S.P. 222.0 Silicon Dioxide 22.0 Mcthylcellulose, U.S.P., 400 cps. 40.0 468.0
Total Weight The penicillin availability is indicated by continu ously recorded fluorometric assay. T and T is time in minutes necessary for dissolution of 50% and 80%,
respectively. of the total potassium penicillin per tablet.
71 in soln in 60 mins.
72 in sol'n T T,. in 30 mins.
Control 25 56 57 82 Tablet (containing unprocessed lubricant) Tablet (made with equivalent amount of enrobed lubricant) bricant being enrobed in a hydrophilic friable sheath,
said sheathing material being selected from the group consisting of mannitol, polyethylene glycol 4,000, 6,000, and 20,000, gelatin, methyl cellulose, carboxymethylcellulose, gum arabic, and polyvinyl alcohol; said enrobed tableting lubricant imparting a reduction in dissolution time to a compacted pharmaceutical dosage form when incorporated in said compacted pharmaceutical dosage form, as compared to said lubricant when not enrobed.
2. The composition of claim 1 wherein the solid hydrophobic tableting lubricant is magnesium stearate and the hydrophilic friable sheathing material is poly ethylene glycol 4000. V
3.'The composition of claim 1 wherein the solid hydrophobic tableting lubricant is magnesium stearate and the hydrophilic friable sheathing material is gelatin.
4. The composition of claim 1 wherein the solid hydrophobic tableting lubricant is calcium stearate and the hydrophilic friable sheathing material is gelatin.
5. The composition of claim 1 wherein the solid hydrophobic tableting lubricant is talc and the hydrophilic friable sheathing material is polyethylene glycol 6,000.
6. A compressed pharmaceutical medicament tablet containing as tableting lubricant a tableting lubricant composition consisting essentially of micropellets of finely divided particles of solid hydrophobic tableting lubricant selected from the group consisting of magnesium stearate, calcium stearate, stearic acid, talcum, and powdered vegetable stearine, a substantial proportion of the particles of said lubricant being enrobed in a hydrophilic friable sheath, said sheathing material being selected from the group consisting of mannitol, polyethylene glycol 4,000, 6,000, and 20,000, gelatin, methyl cellulose, carboxymethylcellulose, gum arabic, and polyvinyl alcohol; said tablet having imparted, by said enrobed lubricant, reduced disintegration time compared to said lubricant if not enrobed.

Claims (6)

1. A TABLETING LUBRICANT COMPOSITION CONSISTING ESSENTIALLY OF MICROPELLETS OF FINELY DIVIDED PARTICLES OF SOLID HYDROPHOBIC TABLETING LUBRICANT SELECTED FROM THE GROUP CONSISTING OF MAGNESIUM STREARATE CALCIUM STEARATE STERARIC ACID TALCUM AND POWDERED VEGETABLE STEARINE A SUBSTANTIAL PROPORTON OF THE PARTICLES OF SAID LUBRICANT BEING ENROBED IN A HYDROPHILIC FRIABLE SHEATH SAID SHEATHING MATERIAL BEING SELECTED FROM THE GROUP CONSISTING OF MANNITOL POLYETHYLENE GLYCOL 4,000 6,000 AND 20,000 GELATIN METHYL CELLULOSE CARBOXYMETHYLCELLULOSE GUM, ARABIC AND POLYVINYL ALCOHOL SAID ENROBED TABLETING LUBRICANT IMPARTING A REDUCTION IN DISSOLUTION TIME TO A COMPACTED PHARMACEUTICAL DOSAGE FORM WHEN INCORPORATED IN SAID COMPACTED PHARMACEUTICAL DOSAGE FORM AS COMPARED TO SAID LUBRICANT WHEN NOT ENROBED.
2. The composition of claim 1 wherein the solid hydrophobic tableting lubricant is magnesium stearate and the hydrophilic friable sheathing material is polyethylene glycol 4000.
3. The composition of claim 1 wherein the solid hydrophobic tableting lubricant is magnesium stearate and the hydrophilic friable sheathing material is gelatin.
4. The composition of claim 1 wherein the solid hydrophobic tableting lubricant is calcium stearate and the hydrophilic friable sheathing material is gelatin.
5. The composition of claim 1 wherein the solid hydrophobic tableting lubricant is talc and the hydrophilic friable sheathing material is polyethylene glycol 6,000.
6. A compressed pharmaceutical medicament tablet containing as tableting lubricant a tableting lubricant composition consisting essentially of micropellets of finely divided particles of solid hydrophobic tableting lubricant selected from the group consisting of magnesium stearate, calcium stearate, stearic acid, talcum, and powdered vegetable stearine, a substantial proportion of the particles of said lubricant being enrobed in a hydrophilic friable sheath, said sheathing material being selected from the group consisting of mannitol, polyethylene glycol 4,000, 6,000, and 20,000, gelatin, methyl cellulose, carboxymethylcellulose, gum arabic, and polyvinyl alcohol; said tablet having imparted, by said enrobed lubricant, redUced disintegration time compared to said lubricant if not enrobed.
US449171A 1971-07-02 1974-03-07 Enrobed solid hydrophobic tableting lubricants and compositions Expired - Lifetime US3908003A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US449171A US3908003A (en) 1971-07-02 1974-03-07 Enrobed solid hydrophobic tableting lubricants and compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15956971A 1971-07-02 1971-07-02
US449171A US3908003A (en) 1971-07-02 1974-03-07 Enrobed solid hydrophobic tableting lubricants and compositions

Publications (1)

Publication Number Publication Date
US3908003A true US3908003A (en) 1975-09-23

Family

ID=26856088

Family Applications (1)

Application Number Title Priority Date Filing Date
US449171A Expired - Lifetime US3908003A (en) 1971-07-02 1974-03-07 Enrobed solid hydrophobic tableting lubricants and compositions

Country Status (1)

Country Link
US (1) US3908003A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127645A (en) * 1976-05-21 1978-11-28 Life Savers, Inc. Effervescent tablet and method
US4254099A (en) * 1978-10-18 1981-03-03 Beiersdorf Aktiengesellschaft Pharmaceutical tablet composition
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4499066A (en) * 1981-08-05 1985-02-12 Farmitalia Carlo Erba S.P.A. Pharmaceutical sustained-release compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20100021540A1 (en) * 2008-02-28 2010-01-28 Abbott Laboratories Tablets and Preparation Thereof
JP2010513329A (en) * 2006-12-20 2010-04-30 ミラン ファーマシューティカルズ ユーエルシー Pharmaceutical composition comprising hot melt granulated lubricant
US20100297268A1 (en) * 2008-01-23 2010-11-25 Fujifilm Corporation Agent for increasing blood adiponectin quantity
AU2014201170B2 (en) * 2006-12-20 2015-09-24 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3210208A (en) * 1962-05-01 1965-10-05 Smith Kline French Lab Process of coating organopolysiloxane particles
US3382150A (en) * 1962-05-01 1968-05-07 Smith Kline French Lab Spray-dried coated organopolysiloxane oral pharmaceutical or veterinary composition
US3518343A (en) * 1967-10-02 1970-06-30 Miles Lab Effervescent tablet and process for making same
US3518345A (en) * 1967-10-05 1970-06-30 Miles Lab Tableting lubricant
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant
US3619462A (en) * 1969-12-29 1971-11-09 Miles Lab Tableting lubricant

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3210208A (en) * 1962-05-01 1965-10-05 Smith Kline French Lab Process of coating organopolysiloxane particles
US3382150A (en) * 1962-05-01 1968-05-07 Smith Kline French Lab Spray-dried coated organopolysiloxane oral pharmaceutical or veterinary composition
US3518343A (en) * 1967-10-02 1970-06-30 Miles Lab Effervescent tablet and process for making same
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant
US3518345A (en) * 1967-10-05 1970-06-30 Miles Lab Tableting lubricant
US3619462A (en) * 1969-12-29 1971-11-09 Miles Lab Tableting lubricant

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127645A (en) * 1976-05-21 1978-11-28 Life Savers, Inc. Effervescent tablet and method
US4254099A (en) * 1978-10-18 1981-03-03 Beiersdorf Aktiengesellschaft Pharmaceutical tablet composition
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4499066A (en) * 1981-08-05 1985-02-12 Farmitalia Carlo Erba S.P.A. Pharmaceutical sustained-release compositions
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
JP2010513329A (en) * 2006-12-20 2010-04-30 ミラン ファーマシューティカルズ ユーエルシー Pharmaceutical composition comprising hot melt granulated lubricant
US20100120723A1 (en) * 2006-12-20 2010-05-13 Mostafa Akbarieh Pharmaceutical composition comprising a hot-melt granulated lubricant
AU2014201170B2 (en) * 2006-12-20 2015-09-24 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
US20100297268A1 (en) * 2008-01-23 2010-11-25 Fujifilm Corporation Agent for increasing blood adiponectin quantity
US20100021540A1 (en) * 2008-02-28 2010-01-28 Abbott Laboratories Tablets and Preparation Thereof

Similar Documents

Publication Publication Date Title
US3670065A (en) Process for producing dosage units of a type resembling tablets
US4483847A (en) Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material
US3279998A (en) Method of preparing sustained release tablets
DE68926432T2 (en) Solid encapsulated drug, method and device for its manufacture
US3147187A (en) Sustained release pharmaceutical
DE69817010T2 (en) SPHEROIDS, PROCESS FOR PRODUCING THE SAME AND MEDICINAL PRODUCTS CONTAINING THEM
US3908003A (en) Enrobed solid hydrophobic tableting lubricants and compositions
DE69123075T2 (en) Coated composition and process for its manufacture
US5453283A (en) Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
US6194005B1 (en) Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
US20090041829A1 (en) Pharmaceutical dosage forms comprising a lipid phase
DE3030622A1 (en) DIVISIBLE TABLET WITH CONTROLLED AND DELAYED DELIVERY OF ACTIVE SUBSTANCES
US3632778A (en) Tablets containing l-dopa
US2841528A (en) Method of making fused tablets
US2757124A (en) Tablets and method of producing same
US4151274A (en) Process and composition for the production of suppositories
US3247064A (en) Multivitamin tablet stabilized with porous silica
US3084104A (en) Process of preparing granulation of medicinal agents
EP0239983B1 (en) Bricks made of pellets
US3857933A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
US3927196A (en) Soluble capsules
DE60027601T2 (en) DRUG PREPARATION WITH CONTROLLED RELEASE CONTAINING TRAMADOL HYDROCHLORIDE
EP0948321B1 (en) Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance
DE60002089T2 (en) LOW-DOSED TABLETS AND METHOD FOR THE PRODUCTION THEREOF
US3655852A (en) Method of forming a stable vitamin e-c granulation